Chest

Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD.  163:502-514. 2023

Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort.  163:515-528. 2023

Clinical Markers Associated With Risk of Suicide or Drug Overdose Among Individuals With Smoking Exposure: A Longitudinal Follow-up Study of the COPDGene Cohort.  163:292-302. 2023

Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection: An International, Multicenter, Retrospective Cohort Study.  162:1384-1392. 2022

Association of Right Ventricular Afterload With Atrial Fibrillation Risk in Older Adults: The Atherosclerosis Risk in Communities Study.  162:884-893. 2022

Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease: Data From the Pulmonary Fibrosis Foundation Patient Registry.  162:603-613. 2022

Resuscitation Quality in the ICU: A Retrospective Analysis.  162:569-577. 2022

Provider Perspectives on and Access to Palliative Care for Patients With Interstitial Lung Disease.  162:375-384. 2022

Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study.  162:145-155. 2022

Response.  161:e398. 2022

Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD.  161:1239-1249. 2022

Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients Receiving Rituximab.  161:1201-1210. 2022

The Role of Palliative Care in COPD.  161:1250-1262. 2022

Longitudinal Association Between Muscle Loss and Mortality in Ever Smokers.  161:960-970. 2022

Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort.  161:949-959. 2022

Bronchial Thermoplasty in Patients With Severe Asthma at 5 Years: The Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma Study.  161:614-628. 2022

Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative.  161:470-482. 2022

Communicating About Time-Limited Trials.  161:202-207. 2022

A 37-Year-Old Man With Interstitial Lung Disease and Progressive Dyspnea..  160:e657-e660. 2021

Emphysema Progression and Lung Function Decline Among Angiotensin Converting Enzyme Inhibitors and Angiotensin-Receptor Blockade Users in the COPDGene Cohort.  160:1245-1254. 2021

Variation in Early Management Practices in Moderate-to-Severe ARDS in the United States: The Severe ARDS: Generating Evidence Study.  160:1304-1315. 2021

Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19.  160:929-943. 2021

The Association Between Lung Hyperinflation and Coronary Artery Disease in Smokers.  160:858-871. 2021

Pulmonary Arterial Pruning and Longitudinal Change in Percent Emphysema and Lung Function: The Genetic Epidemiology of COPD Study.  160:470-480. 2021

Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease: Evidence Review and Practical Considerations..  160:219-230. 2021

Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function.  160:94-103. 2021

Pleural Pressure Targeted Positive Airway Pressure Improves Cardiopulmonary Function in Spontaneously Breathing Patients With Obesity.  159:2373-2383. 2021

Essential Components of an Interstitial Lung Disease Clinic: Results From a Delphi Survey and Patient Focus Group Analysis.  159:1517-1530. 2021

Trends and Geographic Variation in Acute Respiratory Failure and ARDS Mortality in the United States.  159:1460-1472. 2021

Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial.  159:985-995. 2021

A National Survey of Burnout and Depression Among Fellows Training in Pulmonary and Critical Care Medicine: A Special Report by the Association of Pulmonary and Critical Care Medicine Program Directors.  159:733-742. 2021

Clinical Phenotypes of Atopy and Asthma in COPD: A Meta-analysis of SPIROMICS and COPDGene.  158:2333-2345. 2020

Serum IgG Levels and Risk of COPD Hospitalization: A Pooled Meta-analysis.  158:1420-1430. 2020

WHERE'S HER PARENCHYMA? IDIOPATHIC GIANT BULLOUS EMPHYSEMA IN A YOUNG WOMAN.  158:a1163. 2020

Machine Learning and Prediction of All-Cause Mortality in COPD.  158:952-964. 2020

Association of Guideline-Recommended COPD Inhaler Regimens With Mortality, Respiratory Exacerbations, and Quality of Life: A Secondary Analysis of the Long-Term Oxygen Treatment Trial.  158:529-538. 2020

The “Good” Home Death in Pulmonary Disease: Avoiding the “Bad” and the “Ugly”.  158:449-450. 2020

Luminal Plugging on Chest CT Scan: Association With Lung Function, Quality of Life, and COPD Clinical Phenotypes.  158:121-130. 2020

Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.  157:1522-1530. 2020

Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry.  157:1188-1198. 2020

POINT: Are Eosinophils Useful for the Management of COPD? Yes.  157:1073-1075. 2020

Rebuttal From Drs Wade and Wells.  157:1078-1079. 2020

Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD: An Analysis of the SPIROMICS Cohort.  157:856-865. 2020

Preoperative Evaluation of Patients With Interstitial Lung Disease.  156:826-833. 2019

AN UNUSUAL CASE OF DESQUAMATIVE INTERSTITIAL PNEUMONIA RECURRENCE AFTER LUNG TRANSPLANT.  156:a1233. 2019

The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.  156:685-695. 2019

Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study.  156:228-238. 2019

Predictors of Response to Endobronchial Coil Therapy in Patients With Advanced Emphysema.  155:928-937. 2019

Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS.  155:908-917. 2019

Lessons Learned From Web- and Social Media-Based Educational Initiatives by Pulmonary, Critical Care, and Sleep Societies.  155:671-679. 2019

Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study.  155:519-527. 2019

Characteristics and Health-care Utilization History of Patients With Bronchiectasis in US Medicare Enrollees With Prescription Drug Plans, 2006 to 2014.  154:1311-1320. 2018

AN UNUSUAL CAUSE OF ENCEPHALOPATHY: STEROID RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS (SREAT).  154:383a-384a. 2018

Acute Tetrahydrobiopterin Improves Endothelial Function in Patients With COPD.  154:597-606. 2018

Visual Estimate of Coronary Artery Calcium Predicts Cardiovascular Disease in COPD.  154:579-587. 2018

Survival After an ICU Hospitalization for Pulmonary Hypertension.  154:229-231. 2018

Diaphragm Dysfunction in Critical Illness.  153:1040-1051. 2018

Survival of Lung Transplant Candidates With COPD: BODE Score Reconsidered.  153:697-701. 2018

Response.  153:568-569. 2018

Lobar Emphysema Distribution Is Associated With 5-Year Radiological Disease Progression.  153:65-76. 2018

Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry.  152:1120-1127. 2017

Response.  152:1351. 2017

Totally Implantable IV Treprostinil Therapy in Pulmonary Hypertension Assessment of the Implantation Procedure.  152:1128-1134. 2017

Response.  152:1092-1093. 2017

A Multicenter, Randomized Trial of Ramped Position vs Sniffing Position During Endotracheal Intubation of Critically Ill Adults.  152:712-722. 2017

Clinical Outcomes of Weight-Based Norepinephrine Dosing in Underweight and Morbidly Obese Patients.  152:a408. 2017

Hashimoto Encephalopathy: A Rare Autoimmune Encephalopathy Reversible With Steroid Therapy.  152:a360. 2017

Mauriac Syndrome: A Rare Cause of Lactic Acidosis in the ICU.  152:a422. 2017

Monitoring Activity Levels in ICU Survivors With Accelerometers.  152:a394. 2017

Norepinephrine Dosing in Obese Patients: Impact of Weight-Based Dosing on Short- and Long-Term Mortality.  152:a403. 2017

Pulmonary Inflammatory Pseudotumor and Skull Plasma Cell Granuloma as Metachronous Manifestations of IgG4-Related Disease.  152:a719. 2017

Lung Transplant Candidates on Extracorporeal Support.  151:1177-1178. 2017

Liberation From Mechanical Ventilation in Critically Ill Adults: An Official American College of Chest Physicians/American Thoracic Society Clinical Practice Guideline: Inspiratory Pressure Augmentation During Spontaneous Breathing Trials, Protocols Minimizing Sedation, and Noninvasive Ventilation Immediately After Extubation.  151:166-180. 2017

Liberation From Mechanical Ventilation in Critically Ill Adults: Executive Summary of an Official American College of Chest Physicians/American Thoracic Society Clinical Practice Guideline.  151:160-165. 2017

Obesity Is Associated With Increased Morbidity in Moderate to Severe COPD.  151:68-77. 2017

Risk Factors for In-Hospital Mortality in Smoke Inhalation-Associated Acute Lung Injury: Data From 68 United States Hospitals.  150:1260-1268. 2016

A Novel Spirometric Measure Identifies Mild COPD Unidentified by Standard Criteria.  150:1080-1090. 2016

Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial.  150:27-34. 2016

Pulmonary artery enlargement is associated with cardiac injury during severe exacerbations of COPD.  149:1197-1204. 2016

Transcriptional profiling of endobronchial ultrasound-guided lymph node samples aids diagnosis of mediastinal lymphadenopathy.  149:535-544. 2016

Neutrophil Chemoattractant Peptide Proline-Glycine-Proline Is Increased in Acute Respiratory Distress Syndrome.  148:180a. 2015

The Battle of Bleeding and Clotting: Novel Use of Intranasal Bevacizumab in a Patient With Hereditary Hemorrhagic Telangiectasia and Chronic Thromboembolic Pulmonary Hypertension.  148:978a-978b. 2015

The idiopathic pulmonary fibrosis clinical research network (IPFnet): Diagnostic and adjudication processes.  148:1034-1042. 2015

Executive Summary: Prevention of Acute Exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.  147:883-893. 2015

Prevention of Acute Exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.  147:894-942. 2015

Improved clinical and radiographic outcomes after treatment with ivacaftor in a young adult with cystic fibrosis with the P67L CFTR mutation.  147:e79-e82. 2015

Comparing cost of indwelling pleural catheter vs talc pleurodesis for malignant pleural effusion.  146:991-1000. 2014

Disseminated Thrombosis: A Stormy Presentation of a Myeloproliferative Disorder.  146:298a. 2014

Metastatic Papillary Thyroid Carcinoma Presenting as Progressive Dyspnea From ILD.  146:412a. 2014

Prediction of acute respiratory disease in current and former smokers with and without COPD.  146:941-950. 2014

Breath analysis in pulmonary arterial hypertension..  145:551-558. 2014

A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection.  145:848-855. 2014

CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD.  145:824-832. 2014

Prolonged extracorporeal membrane oxygenation use as a bridge to lung transplantation: It is time for a national registry.  145:184-185. 2014

A new approach to classification of disease severity and progression of COPD.  144:1179-1185. 2013

Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD.  144:498-506. 2013

Educating the adolescent and young adult with cystic fibrosis about their reproductive risks and options.  143:580-581. 2013

Effect of emphysema on CT scan measures of airway dimensions in smokers.  143:687-693. 2013

Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism.  143:978-983. 2013

Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation.  144:616-622. 2013

Reduced sodium transport with nasal administration of the prostasin inhibitor camostat in subjects with cystic fibrosis.  144:200-207. 2013

Understanding the relationship between sweat chloride and lung function in cystic fibrosis.  144:1418. 2013

United States critical illness and injury trials group.  143:808-813. 2013

24/7 In-house intensivist coverage and fellowship education: A cross-sectional survey of academic medical centers in the United States.  141:959-966. 2012

ADRB2 polymorphisms and budesonide/formoterol responses in COPD.  142:320-328. 2012

Interpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortality.  141:73-80. 2012

Six-minute walk distance predictors, including CT scan measures, in the COPDGene cohort.  141:867-875. 2012

The relationship between pulmonary emphysema and kidney function in smokers.  142:655-662. 2012

The significance of elevated tumor markers among patients with idiopathic pulmonary fibrosis before and after lung transplantation.  141:1047-1054. 2012

Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis.  140:489-496. 2011

Depression and functional status are strongly associated with dyspnea in interstitial lung disease.  139:609-616. 2011

Fleeting alveolar infiltrates and reversed halo sign in patients with breast cancer treated with tangential beam irradiation.  139:454-459. 2011

Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis.  139:782-787. 2011

Lung transplantation in coal workers pneumoconiosis.  140:1387-1388. 2011

Racial differences in quality of life in patients with COPD.  140:1169-1176. 2011

An international randomized multicenter comparison of nasal potential difference techniques.  138:919-928. 2010

A 30-year-old man with facial flushing and a mediastinal mass.  138:746-749. 2010

Determining the optimal pneumococcal vaccination strategy for adults: Is there a role for the pneumococcal conjugate vaccine?.  138:486-490. 2010

The COPD helplessness index A new tool to measure factors affecting patient self-management.  137:823-830. 2010

Latent TB infection treatment acceptance and completion in the United States and Canada.  137:401-409. 2010

Obesity-asthma association: Is it explained by systemic oxidant stress?.  136:1055-1062. 2009

Soluble P-selectin and the risk of primary graft dysfunction after lung transplantation.  136:237-244. 2009

The metabolic syndrome and pulmonary vascular disease.  136:3-4. 2009

A 65-year-old man with odynophagia and a lung mass.  135:876-879. 2009

Genetic and reproductive knowledge among adolescents and adults with cystic fibrosis.  133:1533. 2008

Pneumococcal vaccination for patients with COPD: Current practice and future directions.  133:767-774. 2008

Tako-tsubo cardiomyopathy: An insight into pathogenesis.  133:583. 2008

Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension.  134:139-145. 2008

Vomiting and diarrhea in a 51-year-old woman with splenectomy.  134:438-441. 2008

Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.  132:185-192. 2007

Gender differences in the severity of CT emphysema in COPD.  132:464-470. 2007

Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy?.  132:798-808. 2007

Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension.  131:453-459. 2007

Pulmonary impairment after tuberculosis.  131:1817-1824. 2007

Right ventricular pressure waveform and wave reflection analysis in patients with pulmonary arterial hypertension.  132:37-43. 2007

Risk indexes for exacerbations due to COPD: Need to validate using broader criteria [3].  132:735. 2007

Shifting the goalpost to stay younger: Normal spirometry but short of breath! [8].  131:1990. 2007

Using the St. George Respiratory Questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis.  132:1591-1598. 2007

Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease.  129:1009-1015. 2006

Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: A prospective study.  130:1791-1795. 2006

Teach a man to fish and you have fed him for a lifetime.  129:220-221. 2006

Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men.  130:1796-1802. 2006

Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem..  128:1989-1994. 2005

Extracellular adenosine triphosphate: A potential regulator of vasa vasorum neovascularization in hypoxia-induced pulmonary vascular remodeling.  128:608S-610S. 2005

Severe acute respiratory syndrome, pulmonary function tests, and quality of life: Lessons learned.  128:1088-1089. 2005

The low-voltage-activated calcium channel CAV3.1 controls proliferation of human pulmonary artery myocytes.  128:581S-582S. 2005

The management of chest tubes in patients with a pneumothorax and an air leak after pulmonary resection.  128:816-820. 2005

Bowel ischemia complicating pneumococcal pneumonia.  126:968s-1-968s-2. 2004

Fast tracking after ivor lewis esophagogastrectomy.  126:1187-1194. 2004

Functional assessment of pulmonary vein stenosis using radionuclide ventilation/perfusion imaging.  126:645-651. 2004

Respiratory syncytial virus causes increased bronchial epithelial permeability.  126:186-191. 2004

Talc pleurodesis: Basic fibroblast growth factor mediates pleural fibrosis.  126:1522-1528. 2004

Video-assisted thoracoscopic surgery using single-lumen endotracheal tube anesthesia.  126:281-285. 2004

Which exercise test should be used for patients with symptomatic COPD?.  126:668-670. 2004

Defensive role of pleural mesothelial cell sialomucins in tumor metastasis.  124:682-687. 2003

Lack of long-term adverse adrenal effects from inhaled triamcinolone: Lung Health Study II.  124:57-62. 2003

The effect of house dust mite aeroallergen and air pollutant exposures during infancy..  123:434S. 2003

The 6-min walk test: A quick measure of functional status in elderly adults.  123:387-398. 2003

A Mycotic Pulmonary Artery Aneurysm Presenting as an Endobronchial Mass.  124:1610-1612. 2003

Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokers.  123:181-186. 2003

Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: Improved completion rates but more hepatotoxicity.  123:102-106. 2003

Tobacco dependence: a chronic disease..  121:686-687. 2002

Effects of training with heliox and noninvasive positive pressure ventilation on exercise ability in patients with severe COPD.  122:464-472. 2002

Enhancement of adenovirus-mediated gene transfer in lungs and epithelial cells by EGTA.  121:35S. 2002

Fatal work-related inhalation of harmful substances in the United States.  121:969-975. 2002

Oral corticosteroids increase esophageal acid contact times in patients with stable asthma.  121:625-634. 2002

Tobacco dependence: A chronic disease.  121:686-687. 2002

Work-related inhalation injuries [2] (multiple letters).  122:1865-1866. 2002

A 53-year-old man with hemoptysis.  120:298-301. 2001

Value of Mycobacterium tuberculosis fingerprinting as a tool in a rural state surveillance program.  120:1877-1882. 2001

The pregnancy that never was - Beta human chorionic gonadotropin secreting primary lung cancer.  118. 2000

Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: Effects of nasal continuous positive airway pressure therapy.  118:591-595. 2000

Pulmonary hypertension causing pulmonary artery aneurysm.  116. 1999

Choosing the appropriate control [2] (multiple letters).  115:1214-1215. 1999

Pulmonary malacoplakia associated with Rhodococcus equi infection in a patient with AIDS.  115:889-892. 1999

Strategies in preserving lung health and preventing COPD and associated diseases: National Lung Health Education Program (NLHEP).  113. 1998

Clinical events detected during pulmonary rehabilitation: Using the ATS staging system as a measure of risk.  114. 1998

Mycobacterium tuberculosis presenting as immune mediated thrombocytopenia purpura.  114. 1998

Can chest CT decrease the use of preoperative bronchoscopy in the evaluation of suspected bronchogenic carcinoma?.  113:1244-1249. 1998

Intrapulmonary shunting in primary pulmonary hypertension: An observation in two patients treated with epoprostenol sodium.  114:334-336. 1998

Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients.  113:1178-1183. 1998

A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group..  112:164-172. 1997

A trial of antioxidants N-acetylcysteine and procysteine in ARDS.  112:164-172. 1997

Airway deposition and clearance and systemic pharmacokinetics of amiloride following aerosolization with an ultrasonic nebulizer to normal airways.  112:1283-1290. 1997

Immediate transcatheter embolization of Swan-Ganz catheter-induced pulmonary artery pseudoaneurysm.  111:1450-1452. 1997

Massive pleural effusion in diffuse granulomatous disease.  112:284-288. 1997

Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management..  110:1305-1316. 1996

Brief vs. extended asthma self-management education.  110. 1996

Angiogenesis in mesotheliomas. Role of mesothelial cell derived IL-8..  109:21S-22S. 1996

Accepting the 'guideline' challenge.  110:1379-1381. 1996

Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study.  109:438-445. 1996

Gastroesophageal reflux-induced bronchoconstriction is microaspiration a factor?.  108:1220-1227. 1995

Invasive diagnostic methods for nosocomial pneumonia: Revisiting the folklore.  108:1492-1494. 1995

Reflex sympathetic dystrophy following arterial blood gas sampling in the intensive care setting.  108:578-580. 1995

Testing the waters: Differentiating transudates from exudates.  108:1191-1192. 1995

Gastroesophageal reflux-induced bronchoconstriction: An intraesophageal acid infusion study using state-of-the-art technology.  106:731-737. 1994

More on asthma prevention [7].  105:1906. 1994

Occupational exposure to tuberculosis: Risk and consequences.  106:658-659. 1994

Transesophageal imaging in Cor triatriatum.  105:332-333. 1994

Functional and phenotypic properties of the CD4+ T cell population in a murine pulmonary delayed-type hypersensitivity response..  103:138S. 1993

A catastrophe is brewing.  103:332-334. 1993

A computer-controlled ventilator weaning system: A clinical trial.  103:1220-1226. 1993

Asthma prevention [3].  104:325-326. 1993

Fluid bronchogram: A common finding in opacified lung requiring contrast medium administration for demonstration.  104:960-962. 1993

Pleural effusion in patients with systemic cholesterol embolization.  103:792-795. 1993

Pulmonary atelectasis and dysphagia in a 69-year-old cachectic man.  103:917-919. 1993

Unilateral absence of a pulmonary artery; Data from cardiopulmonary exercise testing.  103:293-295. 1993

Asthma prevention. Task Force on Research and Education for the Prevention and Control of Respiratory Diseases..  102:216S-231S. 1992

Asthma prevention.  102:216S-231S. 1992

Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus.  102:1171-1174. 1992

Bronchoscopy in North America; The ACCP survey [13].  102:1638-1640. 1992

Diverse roentgenographic manifestations of the rare pulmonary involvement in myeloma.  102:946-948. 1992

Nontuberculous mycobacteria in adult patients with cystic fibrosis.  102:70-75. 1992

Pulmonary barotrauma in mechanical ventilation; Patterns and risk factors.  102:568-572. 1992

Utilization of acute bronchodilator responses in stable COPD to predict the relative efficacy of individual agents.  101:1552-1557. 1992

A computer-controlled ventilator weaning system.  100:1096-1099. 1991

Apical Pneumocystis carinii pneumonia in AIDS patients not receiving inhaled pentamidine prophylaxis.  100:1462-1464. 1991

Long-term oxygen therapy.  100:544-549. 1991

Medication adherence patterns in chronic obstructive pulmonary disease.  99:837-841. 1991

Snoring (I): Daytime sleepiness in regular heavy snorers.  99:40-48. 1991

Unusual initial calcification of primary and metastatic seminomas; Detection by computed tomography.  99:1543-1545. 1991

Characteristics and correlates of asthma in a university clinic population.  98:821-828. 1990

High frequency jet ventilation and intermittent positive pressure ventilation. Effect of cerebral blood flow in patients after open heart surgery.  97:420-424. 1990

Prostacyclin but not phentolamine increases oxygen consumption and skin microvascular blood flow in patients with sepsis and respiratory failure.  98:1467-1472. 1990

Use of Doppler echocardiography and amyl nitrite inhalation to characterize left ventricular outflow obstruction in hypertrophic cardiomyopathy.  97:389-395. 1990

When does bronchial arterial embolization fail to control hemoptysis?.  97:515-516. 1990

Cardiovascular effects of high-frequency oscillatory and jet ventilation.  96:1400-1404. 1989

Computed tomographic detection of cavitary lung lesion complicating use of flow-directed ballon-tipped catheter.  96:432-434. 1989

Cystic fibrosis tracheobronchial effluent stimulates proliferation of lung fibroblasts in vitro.  95:234S-236S. 1989

Does intraeosphageal acid trigger bronchial asthma? No, but maybe yes!.  96:963-964. 1989

Left ventricular dysfunction in symptomatic mitral valve prolapse.  95:370-373. 1989

Mechanisms of pleural fibrosis in empyema. Pleural macrophage-mediated inhibition of fibroblast proliferation.  95. 1989

Selection of patients with acute pulmonary embolism for thrombolytic therapy. Thrombolysis in pulmonary embolism (TIPE) patient survey.  95:279S-281S. 1989

Aspiration resulting from gastroesophageal reflux; a cause of chronic bronchopulmonary disease.  93:676-677. 1988

Transbronchial biopsy without fluoroscopy. A seven-year perspective.  94:557-560. 1988

Treatment of histoplasmosis and blastomycosis.  93:848-851. 1988

Antiviral therapy and pulmonary disease.  91:246-251. 1987

Biologic and biochemical characterization of a macrophage-derived growth factor for rat lung fibroblasts.  91:15s-16s. 1987

Bochdalek hernia of diaphgram in the adult: Diagnosis by computed tomography.  92:1098-1101. 1987

Inverse ratio ventilation. PEEP in disguise?.  92:390-392. 1987

Nasal continuous positive airway pressure in atelectasis.  92:621-624. 1987

Regulation of differentiation of airway epithelial cells.  91:22s-23s. 1987

Relationship of the ventilatory response to cotton bract extract and the cells and proteins of the lung.  91:44-48. 1987

Reduction in bleomycin-induced lung hydroxyproline content by an iron chelating agent..  89:123S-125S. 1986

Bilateral hilar enlargement and hypoperfusion of the right lower lobe.  90:120-121. 1986

Coronary artery cardiomyopathy. Hemodynamic and prognostic implications.  89:352-356. 1986

Giant cell carcinoma of the lung. Clinical and roentgenographic manifestations.  89:366-369. 1986

Potential value of digital radiography. Preliminary observations on the use of dual-energy subtraction in the evaluation of pulmonary nodules.  89:249S-252S. 1986

Reduction in bleomycin-induced lung hydroxyproline content by an iron chelating agent.  89:123S-125S. 1986

Preventive treatment of tuberculosis..  87. 1985

Left ventricular dilatation. Prognostic value in severe left ventricular dysfunction secondary to coronary artery disease.  88:215-220. 1985

Primary coronary artery dissection.  87:227-228. 1985

Pulmonary hypertension in the interstitial lung diseases.  87:558-560. 1985

Smoking cessation.  88:322-324. 1985

Resting kinetics of thallium-201 in patients with coronary artery disease.  86:213-218. 1984

Lung repair and granuloma formation. Tubercle bacilli stimulated neutrophils release chemotactic factors for monocytes..  83:95S-96S. 1983

Current therapy of pulmonary and disseminated fungal diseases.  83:911-917. 1983

Effect of oral disopyramide therapy on left ventricular function.  83:480-484. 1983

Lung repair and granuloma formation. Tubercle bacilli stimulated neutrophils release chemotactic factors for monocytes.  83:95S-96S. 1983

Lupus pleuritis. Clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies.  84:714-718. 1983

The pleuropulmonary manifestations of the postcardiac injury syndrome.  84:383-387. 1983

Treatment of atypical mycobacterial disease.  84:625-628. 1983

Ultrastructural subtypes of pulmonary adenocarcinoma. A correlation with patient survival.  84:581-586. 1983

Changes in pulmonary blood volume during upright exercise. Clinical implications.  82:54-58. 1982

Exercise thallium 201 scintigraphy in evaluating aortocoronary bypass surgery.  80:11-15. 1981

Spasm of a saphenous vein bypass graft. A possible mechanism for occlusion of the venous graft.  80:413-415. 1981

Changes in intrapulmonary shunting with administration of 100% oxygen.  77:138-141. 1980

Coronary angiography soon after myocardial infarction.  77:58-64. 1980

Exercise myocardial scintigraphy with ²⁰¹thallium. Use in patients with mitral valve prolapse without associated coronary artery disease.  77:47-52. 1980

Prevalence of mural thrombi and systemic embolization with left ventricular aneurysm. Effect of anticoagulation therapy.  77:463-469. 1980

Real time two-dimensional echocardiography in the diagnosis of left atrial myxoma.  78:788-791. 1980

Chronotropic and dromotropic effects of histamine on the canine heart.  75:597-604. 1979

Duration of action of isosorbide dinitrate.  75:2-4. 1979

Deep venous thrombosis of the upper extremity associated with use of the Swan-Ganz catheter.  73:673-675. 1978

Pulmonary consolidation associated with infusion of a glucose insulin potassium solution in acute myocardial infarction.  73:179-182. 1978

Tuberculosis and alcoholism. A partial solution through detection.  73:183-185. 1978

Both direct and neurally mediated components of the chronotropic actions of aminophylline.  70:24-32. 1976

Direct and vagally mediated chronotropic effects of morphine studied by selective perfusion of the sinus node of awake dogs.  68:222-228. 1975

Echocardiography in chronic rheumatic mitral valve disease.  68:569-572. 1975

Morphine and autonomic control of the sinus node.  64:203-212. 1973

Pulmonary cavitary lesion with productive cough.  64:109-110. 1973